Kiven Erique Lukong (K E Lukong)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Epithelial Mesenchymal Transition

Breast Cancer Risk

Tyrosine Kinase

Top Venues

Science advances

Journal of cancer research and clinical oncology

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Aditya Mandapati, Kiven Erique Lukong
Triple negative breast cancer: approved treatment options and their mechanisms of action. Journal of cancer research and clinical oncology (2022)
Md Sayem Miah, C A S Banks, Y Ogunbolude, E T Bagu, J M Berg, A Saraf, T T Tettey, G Hattem, G Dayebgadoh, C G Kempf, M Sardiu, S Napper, Laurence A Florens, Kiven Erique Lukong, Michael P Washburn
BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential. Science advances 5 (10) (2019)
Kiven Erique Lukong, Yetunde Ogunbolude, Jean Paul Kamdem
Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants. Breast cancer research and treatment 166 (2) (2017)